Molecular docking studies of abelmoschus esculentus for anti diabetics and anti inflammatory

Authors

  • M.S. Kumaran Gensilico Bio Solution, West Tambaram, Chennai-45
  • P. Sivaselvi Department of Bioinformatics, Sri Krishna Arts and Science College, Coimbatore, India
  • P. Brindha Department of Bioinformatics, Sri Krishna Arts and Science College, Coimbatore, India
  • T. Vimala Department of Bioinformatics, Sri Krishna Arts and Science College, Coimbatore, India

Keywords:

Molecular docking, Argus lab, Mafa, Mmp9, Abelmoscus esculentus

Abstract

Okra (Abelmoschus esculentus (L) Moench) or bhendi also known as ladies’ finger is an important vegetable crop in India, and African regions. Abelmoscus esculentus having the medicinal property of anti-inflammatory, anti-diabetics, anti-oxidant activities. In these studies, we are going to analysis the anti-diabetics and anti-inflammatory property of Abelmoscus esculentus by using molecular docking studies. Diabetics is a major cause of death and the number of new cases, as well as the number of individuals living with Diabetics, is expanding continuously. Now a days It is one of the most common diseases in the worldwide. Foot ulceration remains a major health problem for diabetic patients and has a major impact on the cost of diabetes treatment. One major complication of diabetes is foot ulceration, which occurs in as many as 15–25% of type 1 and type 2 diabetic patients over their lifetimes. The phytochemicals of Abelmoscus esculentus are analysed and optimized with the Arguslab to investigate the interactions between the target compounds and the amino acid residues of the Mafa and Mmp9. All the compound has shown binding pose between from – 3.25 to -7.95 and -7.95 into -11.40 out of ten compounds.  [E,E] Farenesal  with Mafa  protein and  gossypol with Mmp9  protein show best ligand energy -10.55  and -8.88 Kcal/mol  with  1 and 1 hydrogen  bond  of distance is 3.0 and 2.3 respectively .

Downloads

Published

2014-03-01

How to Cite

M.S. Kumaran, P. Sivaselvi, P. Brindha, & T. Vimala. (2014). Molecular docking studies of abelmoschus esculentus for anti diabetics and anti inflammatory. World Journal of Pharmaceutical Sciences, 2(3), 253–258. Retrieved from https://wjpsonline.com/index.php/wjps/article/view/molecular-docking-abelmoschus-esculentus-anti-diabetics

Issue

Section

Research Article